CClinicalTrials.gg
RecruitingNCT07528300Updated Apr 14, 2026

Effect of Battlefield Acupuncture on Pain Control During Inpatient Treatment of Exertional Rhabdomyolysis

An interventional study of Battlefield Acupuncture in Rhabdomyolysis, sponsored by Tripler Army Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-14.

Sponsored by Tripler Army Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Non-randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Patients admitted with exertional rhabdomyolysis will be offered treatment with battlefield acupuncture for pain management and compared with patient's pain levels and pain medication requirements with those patients who declined battlefield acupuncture.

Read the detailed description

Pilot study using a prospective observational case series of patients admitted to Tripler Army Medical Center who meet CHAMP criteria for rhabdomyolysis and who elect to undergo BFA in addition to standard of care pain control. We will not blind patients, providers, or research coordinators. Goal is to administer BFA within 12 hours of inpatient admission and monitor the pain response.

02

Conditions studied

  • Rhabdomyolysis

Keywords

  • battlefield acupuncture
  • rhabdomyolysis
  • pain management
03

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Rhabdomyolysis
  • chooses battlefield acupuncture

Exclusion criteria

Exclusion Criteria:

  • Greater than 72 hours from onset of symptoms
  • younger than 18 years of age
  • declines battlefield acupuncture
  • no pain
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    Battlefield Acupuncture

    Patients admitted with rhabdomyolysis who choose to get battlefield acupuncture for pain control.

    Procedure: Battlefield Acupuncture

  • No intervention
    Patients admitted with rhabdomyolysis who did not receive battlefield acupuncture

    This arm is the retrospective group that did not receive the BFA as an intervention.

Interventions

  • ProcedureBattlefield Acupuncture

    Treatment of pain from rhabdomyolysis with battlefield acupuncture

05

What researchers measure

Primary outcomes

  1. Pain Level on a pain scale of 0-10

    Reported pain levels on a subjective pain score of 0-10

    Time frame: Pain level will be measured through study completion (up to 12 months).

  2. Pain Medication

    Amount of pain medication required, Morphine equivalent and acetaminophen use on hospital days 1-7

    Time frame: From enrollment to the end of treatment at 12 months

Secondary outcomes

  1. Length of Hospital Stay in days

    How long the patient stays in the hospital in days

    Time frame: Length of time from admission to discharge in days (up to 7 days)

06

Study locations

1 of 1 sites recruiting
07

References and documents

Individual participant data

Plan to share: No — No plan to be shared.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07528300
Lead sponsor
Tripler Army Medical Center
Responsible party
Chelsea Tagawa (Principal Investigator, Tripler Army Medical Center) — Principal investigator
First posted
Apr 14, 2026
Start date
Apr 24, 2023
Primary completion
Apr 24, 2028 (estimated)
Completion
Apr 24, 2028 (estimated)
Last update
Apr 14, 2026

Study contacts

Chelsea W Tagawa, MD
Contact
chelsea.w.tagawa.civ@health.mil
808-433-2202
Susan A Scrivner, MS
Contact
susan.a.scrivner.ctr@health.mil
808-433-5486
Chelsea W Tagawa, MD
principal investigator · Tripler Army Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion